Webinare

Next-Generation Sequencing of Immunoglobulin Genes in Lymphoid Malignancies

5 May 2022

May 19 at 10 am PT | 1 pm ET | 7 pm CEST
online
Duration: 1 hour

Tags: Invivoscribe, Leukemia , Leukämie, Lymphoid Malignancies, Next-Generation Sequencing, NGS, Klonalität , Clonality , IVS, webinar, B-Zellen, B-cells

Innovation in 3D cell culture: creating a customizable microenvironment to replicate in vivo properties of tissues

30 Mar 2022

on demand webinar

Tags: Cell Guidance Systems, 3D cellculture , physiologically-relevant microenvironment , webinar

IVDR compliant use of LDTs in the laboratory

8 Mar 2022

The IVDR comes into effect on 5/25/2022 and provides new rules for homegrown tests (homebrew/LDTs)
Dr. Andreas Eckelt (IVDRconsulting)

Tags: LGC Clinical Diagnostics, Reference Materials, Seraseq, LGC Seracare, Referenzmaterial, Oncology, NIPT, NGS, CE-IVD, IVDR, DNA Diagnostics, HiSS Diagnostics Solution, LDT, Laboratory Developed Tests

Understanding and Clarifying the Complexities of HRD Measurements in Cancer

23 Feb 2022

• Ravindra Kolhe, MD, PhD • David Fabrizio, PhD • John Jiang, PhD • Yves Konigshofer, PhD
• available On Demand at genomeweb

Tags: LGC Clinical Diagnostics, Immuno-Oncology, Reference Materials, Seraseq, LGC Seracare, Referenzmaterial, Tumor Profiling, HRD, Biomarker, ADP-Ribose, PARPi, Oncology

Stratification and Prognoses of Leukemia and Multiple Myeloma using Next-Generation Sequencing

17 Feb 2022

• Prognostication of Chronic Lymphocytic Leukemia (CLL) using NGS
• Evaluation of Strategies to Leverage NGS-based Minimal Residual Disease (MRD) in Multiple Myeloma (MM) and Acute Lymphoblastic Leukemia (ALL)

Tags: Invivoscribe, Leukemia , Multiple Myeloma, Morbus Kahler , Leukämie, ALL , Akute Lymphatische Leukämie, MRD, Messbare (minimale) Resterkrankung (MRD), Minimal Residual Disease (MRD)

The use of Seraseq® Oncology controls & NGS validation challenges

7 Feb 2022

Video recording of the lecture:
- Tumor Profiling - Liquid Biopsy -Immuno-Oncology

Tags: LGC Clinical Diagnostics, Immuno-Oncology, Liquid Biopsy, Reference Materials, LoD, Nachweisgrenze, Sensitivität, Seraseq, LGC Seracare, Referenzmaterial, Tumor Profiling

Review of Guidelines for Interpreting Somatic Hypermutation Status

26 Jan 2022

in Chronic Lymphocytic Leukemia in the Era of High-Throughput Sequencing

Tags: CLL, SHM status , chronic lymphocytic leukemia, somatic hypermutation , next-generation sequencing , NGS, IVS, Invivoscribe

Challenging the Limit of Detection in Liquid Biopsy Assays

2 Dec 2021

In this presentation, Ms. Krystyna Nahlik, PhD will present studies on the impact of reference materials on the limit of detection (LoD) and sensitivity in liquid biopsy testing:
- Seraseq® ctDNA Complete
- Seraseq® ctDNA v2
- Seraseq® ctDNA MRD panel

Tags: LGC Clinical Diagnostics, Liquid Biopsy, Reference materials, LoD, Nachweisgrenze, Sensitivität, Seraseq, Seracare, Referenzmaterial

Molecular FLT3 diagnostics in AML

26 Mar 2021

Practical example from the

Tags: FLT3, Leukostrat, Invivoscribe, AML, IVDR